rs199730337
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBA1
The NM_138425.4(C12orf57):c.229+25_229+43del variant causes a splice donor 5th base, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0144 in 1,610,452 control chromosomes in the GnomAD database, including 1,090 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.045 ( 386 hom., cov: 32)
Exomes 𝑓: 0.011 ( 704 hom. )
Consequence
C12orf57
NM_138425.4 splice_donor_5th_base, intron
NM_138425.4 splice_donor_5th_base, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.05
Genes affected
C12orf57 (HGNC:29521): (chromosome 12 open reading frame 57) This gene is ubiquitously expressed in human tissues. It is required for development of the human corpus callosum. Mutations in this gene are associated with Temtamy syndrome (TEMTYS). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
PP3
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
BP6
Variant 12-6944654-TGGGTCAGACGCGGGAAGGC-T is Benign according to our data. Variant chr12-6944654-TGGGTCAGACGCGGGAAGGC-T is described in ClinVar as [Likely_benign]. Clinvar id is 466308.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.117 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C12orf57 | NM_138425.4 | c.229+25_229+43del | splice_donor_5th_base_variant, intron_variant | ENST00000229281.6 | NP_612434.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C12orf57 | ENST00000229281.6 | c.229+25_229+43del | splice_donor_5th_base_variant, intron_variant | 1 | NM_138425.4 | ENSP00000229281 | P1 | |||
ENST00000607421.2 | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.0451 AC: 6856AN: 151972Hom.: 383 Cov.: 32
GnomAD3 genomes
AF:
AC:
6856
AN:
151972
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0305 AC: 7625AN: 250344Hom.: 406 AF XY: 0.0235 AC XY: 3182AN XY: 135656
GnomAD3 exomes
AF:
AC:
7625
AN:
250344
Hom.:
AF XY:
AC XY:
3182
AN XY:
135656
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0112 AC: 16262AN: 1458362Hom.: 704 AF XY: 0.0101 AC XY: 7288AN XY: 724718
GnomAD4 exome
AF:
AC:
16262
AN:
1458362
Hom.:
AF XY:
AC XY:
7288
AN XY:
724718
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0453 AC: 6888AN: 152090Hom.: 386 Cov.: 32 AF XY: 0.0449 AC XY: 3338AN XY: 74346
GnomAD4 genome
AF:
AC:
6888
AN:
152090
Hom.:
Cov.:
32
AF XY:
AC XY:
3338
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
81
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia | Apr 14, 2015 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 07, 2021 | - - |
Temtamy syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at